Alzheimer's patients have Type 2 diabetes, which is associated with increased Advanced Glycation End Products (AGEs) and increased expression of the AGED receptor.
Advanced glycation end products (AGEs) are lipid or protein materials that become exceptionally glycated because of contact with sugars. They are a bio-marker embroiled in ...
